Made In USAFor Laboratory Research OnlyCOAs Not Yet AvailableExplore Compound Research ProfilesCompare Catalog SizesResearch Requests Reviewed IndividuallyNot For Human Or Veterinary Use
Single compound

NAD+

Catalog size
$63
USD per vial · 500 mgCatalog price
Research only

NAD+ is an endogenous coenzyme central to cellular energy and signaling, with research spanning mitochondrial transport, aging biology and the metabolism of administered NAD+.

Explore the research profile

Submit an unpaid laboratory order request for manual review. Availability and any pending amounts require confirmation.

No reservation or purchase is made by adding a material.
View documentation status ← Back to collection
Material
NAD+
Format
Awaiting confirmation
Availability
Confirmed during review

Catalog quantities are not assay results.

In the literature

A closer look at the science.

Redox coenzyme

What is NAD+?

Nicotinamide adenine dinucleotide in its oxidized form, NAD+, is a nucleotide coenzyme rather than a peptide. Its reduced counterpart is NADH. NAD+ itself must also be distinguished from nicotinamide, nicotinamide riboside and nicotinamide mononucleotide, which participate in related but nonidentical metabolic pathways.

Reference identity
Research class
Redox coenzyme
Catalog search names
NAD
Chemical class
Nucleotide coenzyme
Named form
Oxidized nicotinamide adenine dinucleotide

This reference describes the published literature. Exact supplied form and chemical specifications require product-specific documentation. The studies are linked in Selected literature.

Mechanisms under investigation

By cycling between NAD+ and NADH, the coenzyme transfers electrons during nutrient metabolism and mitochondrial energy production. It is also consumed by enzymes involved in ADP-ribosylation and deacetylation. Extracellular NAD+ may undergo breakdown before its components contribute to intracellular pools, so adding it outside cells does not necessarily increase every tissue compartment directly.

Documented lines of inquiry

Research areas

  1. 01

    Human metabolite handling

    A small pilot study followed plasma and urinary metabolites during controlled NAD+ infusion. It documented time-dependent metabolism and excretion, including an initial period without a plasma NAD+ increase. The study was designed to examine metabolic handling, not disease treatment. [1]

  2. 02

    Extracellular breakdown

    Experiments in human HEK293 cells showed that both cells and culture medium can transform extracellular NAD-related compounds. Under the tested conditions, cleavage contributed to use of extracellular nucleotides for maintaining intracellular NAD, highlighting the importance of culture conditions. [2]

  3. 03

    Cellular energy and aging

    Cell experiments identified SLC25A51 as a mitochondrial NAD+ transporter; disrupting it reduced mitochondrial NAD+ and respiration without lowering whole-cell NAD+. Separately, measurements from 49 human skin samples linked older age with lower NAD+ levels. These findings motivate energy and aging research but do not show that administered NAD+ increases vitality or slows aging. [3][4]

Study topics describe the cited models, not established benefits of this catalog material.

Reading the evidence

What the studies
can tell us.

Human metabolism and tissue studies with cell evidence

The direct-NAD+ human pilot included eight exposed participants and three controls and measured metabolite handling. The skin study examined an age association in one tissue, while cell experiments investigated processing and mitochondrial transport. Together they describe different parts of NAD+ biology; a change in one measured compartment does not establish improvement in whole-body function.

What remains uncertain

These studies do not establish anti-aging, cognitive, addiction-treatment or performance benefits. Results from NR or NMN studies cannot be relabeled as evidence for administered NAD+. Route and formulation matter, and published research does not verify the stability, identity or equivalence of the WYZ catalog material.

Read the source

Selected literature

Primary studies and clearly identified supporting sources. Each link opens the original record.

  1. 01PubMed
  2. 02
    2019 · Cell study

    Degradation of Extracellular NAD+ Intermediates in Cultures of Human HEK293 Cells (opens a new tab)

    Cell- and medium-dependent extracellular degradation and precursor utilization.

    PubMed
  3. 03
    2020 · Cell study

    SLC25A51 is a mammalian mitochondrial NAD+ transporter (opens a new tab)

    Cell and isolated-mitochondria experiments on NAD+ uptake and respiration; not a supplementation trial.

    PubMed
  4. 04
    2012 · Human tissue study

    Age-associated changes in oxidative stress and NAD+ metabolism in human tissue (opens a new tab)

    Cross-sectional measurements in 49 skin samples; an age association rather than an intervention.

    PubMed

Literature reviewed October 2026. This is a selected research overview, not an exhaustive systematic review. Published findings do not establish the identity, purity, sterility or suitability of any WYZ batch. For laboratory research only; not for human or veterinary use.

Before you begin

The details behind
the material.

Specifications and storage

Final product specifications and product-specific storage instructions have not been supplied. Review the original documentation and your laboratory’s procedures before obtaining or using the material.

Research use only

For qualified laboratory researchers. Not for human or veterinary use. Product information is not medical advice or a recommendation for personal use.

What to look for in a COA
Before you explore

Laboratory
research only.

Please confirm the following to enter the Wyz Labs collection.

Select both confirmations to continue.

Your acknowledgment is remembered for this browser session. This is a self-declaration, not identity verification.